Azitra shares are trading higher after it announced it's pursuing new commercial opportunities in cosmetic skincare and leveraging its platform to explore broader applications in biotech products and recombinant proteins. Also, the CEO expects the programs will be in a position to be partnered or commercialized in the next 36 months.